BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1338777)

  • 1. ACE inhibition in the tissues.
    Unger T; Gohlke P
    Clin Physiol Biochem; 1992; 9(3):89-93. PubMed ID: 1338777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue renin-angiotensin systems: fact or fiction?
    Unger T; Gohlke P; Paul M; Rettig R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S20-5. PubMed ID: 1725037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE).
    Xiao HD; Fuchs S; Frenzel K; Teng L; Bernstein KE
    Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):137-45. PubMed ID: 15104531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physiological significance of the alternative pathways of angiotensin II production.
    Kramkowski K; Mogielnicki A; Buczko W
    J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of angiotensin II in diabetic nephropathy.
    Kennefick TM; Anderson S
    Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
    de Resende MM; Mill JG
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition.
    Vaughan DE
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-34-7. PubMed ID: 9422850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
    Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives.
    Schölkens BA; Linz W
    Clin Physiol Biochem; 1990; 8 Suppl 1():33-43. PubMed ID: 2147878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
    Kurdi M; De Mello WC; Booz GW
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma renin activity and changes in tissue angiotensin converting enzyme.
    Michel B; Grima M; Stephan D; Coquard C; Welsch C; Barthelmebs M; Imbs JL
    J Hypertens; 1994 May; 12(5):577-84. PubMed ID: 7930558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal angiotensin: origin and site of generation.
    van Kats JP; Chai W; Duncker DJ; Schalekamp MA; Danser AH
    Am J Hypertens; 2005 Aug; 18(8):1104-10. PubMed ID: 16109325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new look at the renin-angiotensin system--focusing on the vascular system.
    Nguyen Dinh Cat A; Touyz RM
    Peptides; 2011 Oct; 32(10):2141-50. PubMed ID: 21945916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular tissue renin-angiotensin system in hypertensive humans.
    Taddei S; Salvetti A
    J Hypertens Suppl; 1992 Dec; 10(7):S165-72. PubMed ID: 1337912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue renin-angiotensin system: a site of drug action?
    Zimmerman BG; Dunham EW
    Annu Rev Pharmacol Toxicol; 1997; 37():53-69. PubMed ID: 9131246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.